Cover Image

Treatment interruption of biological drugs and tofacitinib in rheumatoid arthritis: A systematic review of case reports

The aim of this study was to evaluate interruption of treatment with biological drugs and tofacitinib due to adverse events in patients with rheumatoid arthritis. A systematic review was performed in the electronic databases MEDLINE, Cochrane, Scopus, CRD, IPA, Lilacs and Scielo. Case reports addres...

Full description

Saved in:

Bibliographic Details
Main Authors:	Astrid Wiens (Author), Helena Hiemisch Lobo Borba (Author), Letícia Paula Leonart (Author), Fernanda Stumpf Tonin (Author), Laiza Maria Steimbach (Author), Ariane Gonçalves Silva de Araújo (Author), Thais Piazza (Author), Vinicius Lins Ferreira (Author), Roberto Pontarolo (Author)
Format:	Book
Published:	Universidade de São Paulo, 2019-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

<b>New drugs for the treatment of agitation in schizophrenia: a systematic review and meta-analysis of inhaled loxapine and infused sodium nitroprusside
by: Fernanda Stumpf Tonin, et al.
Published: (2017)

Efficacy, safety and tolerability of using abatacept for the treatment of rheumatoid arthritis
by: Rafael Venson, et al.
Published: (2012)

Use of YAKVINUS® (tofacitinib) for the treatment of rheumatoid arthritis
by: article Editorial
Published: (2018)

Clinical scenarios-based guide for tofacitinib in rheumatoid arthritis
by: Mahta Mortezavi, et al.
Published: (2023)

European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib
by: Kawalec P, et al.
Published: (2017)

Pharmacovigilance: an evaluation on the practice of pharmacists acting in pharmacies and drugstores
by: Mayra Bruna Fedalto, et al.
Published: (2022)

Co-Delivery of Loxoprofen and Tofacitinib by Photothermal Microneedles for Rheumatoid Arthritis Treatment
by: Yi Lu, et al.
Published: (2023)

Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis
by: Cutolo M, et al.
Published: (2013)

Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real‐world data
by: Ali Ekin, et al.
Published: (2024)

Tofacitinib Decreases Autophagy of Fibroblast-Like Synoviocytes From Rheumatoid Arthritis Patients
by: M. Vomero, et al.
Published: (2022)

Changes in Serum Cytokines May Predict Therapeutic Efficacy of Tofacitinib in Rheumatoid Arthritis
by: Yuxuan Li, et al.
Published: (2019)

Successful treatment of rheumatoid neutrophilic panniculitis with tofacitinib
by: Hiram Larangeira de Almeida Junior, et al.
Published: (2024)

Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study
by: Borba HHL, et al.
Published: (2017)

Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
by: Sarah Choe, et al.
Published: (2024)

Efficacy and safety of immunotherapies for the treatment of high-grade gliomas: a systematic review and meta-analysis
by: Edilaine Tiburcio da Silva, et al.
Published: (2022)

Efficacy and safety of immunotherapies for the treatment of high-grade gliomas: a systematic review and meta-analysis
by: Edilaine Tiburcio da Silva, et al.
Published: (2022)

Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan
by: Ko-Jen Li, et al.
Published: (2021)

Helicobacter canis bacteraemia in a rheumatoid arthritis patient treated with tofacitinib: case report and literature review
by: Matic Mihevc, et al.
Published: (2021)

Seronegative cutaneous rheumatoid nodules with positive response to tofacitinib
by: Matthew Helm, MD, et al.
Published: (2024)

Psoriatic arthritis - Tofacitinib as a new treatment
by: Marta Skorupska, et al.
Published: (2024)

Tofacitinib pharmacokinetics in children and adolescents with juvenile idiopathic arthritis
by: Cheng Chang, et al.
Published: (2024)

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives
by: Ly K, et al.
Published: (2019)

Risk of dyslipidemia and major adverse cardiac events with tofacitinib versus adalimumab in rheumatoid arthritis: a real-world cohort study from 7580 patients
by: Xiao-Na Ma, et al.
Published: (2024)

Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy
by: M. Tasso, et al.
Published: (2022)

Tofacitinib
by: Nilgün Şentürk
Published: (2022)

Quality of life perception of type 1 diabetic patients treated with insulin analogs and receiving medication review with follow-up in a public health care service from Ponta Grossa-PR, Brazil
by: Aline Ansbach Garabeli, et al.

Tofacitinib: Revisión
by: Carlos Ríos Acosta, et al.
Published: (2016)

Rheumatoid Arthritis
Published: (2022)

Rheumatoid arthritis
by: Yoshiya Tanaka
Published: (2020)

Rheumatoid Arthritis Treatment
Published: (2012)

Skin in rheumatoid arthritis and seronegative arthritis
by: Pragathi Sankineni, et al.
Published: (2019)

Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
by: Tanja Todberg, et al.
Published: (2020)

SDRIFE Induced by Tofacitinib
by: Ramachandran Gnanasuriyan, et al.
Published: (2024)

Rehabilitation in rheumatoid arthritis
by: Anna Golus, et al.
Published: (2018)

Rehabilitation in rheumatoid arthritis
by: Anna Golus, et al.
Published: (2018)

Early rheumatoid arthritis
by: P. Sarzi-Puttini, et al.
Published: (2011)

Rheumatoid arthritis and atherosclerosis
by: B. Seriolo, et al.
Published: (2003)

Leishmaniasis in rheumatoid arthritis
by: M. Cutolo, et al.
Published: (2011)

Biomarkers in Rheumatoid Arthritis
by: Vincent Goëb, et al.
Published: (2014)

Atherosclerosis in Rheumatoid Arthritis
by: Miguel A. González-Gay, et al.
Published: (2012)